Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

First study to focus on platelet genetics in African Americans

Researchers, led by scientists from Johns Hopkins, have found five previously unknown gene mutations believed to be associated with elevated blood platelet counts in African-Americans, findings they say could someday lead to the development of new drugs to help prevent coronary artery disease.

2 Mar 2012

Study uncovers how FoxO1 protein contributes to heart disease in patients with diabetes

UT Southwestern Medical Center cardiologists have uncovered how a specific protein's previously unsuspected role contributes to the deterioration of heart muscle in patients with diabetes. Investigators in the mouse study also have found a way to reverse the damage caused by this protein.

2 Mar 2012

Serum taurine may protect against CHD in women with high cholesterol

A nutrient found in the dark meat of poultry may provide protection against coronary heart disease (CHD) in women with high cholesterol, according to a study by researchers at NYU Langone Medical Center.

2 Mar 2012

Cold air can trigger coronary events

People with heart disease may not be able to compensate for their bodies' higher demand for oxygen when inhaling cold air, according to Penn State researchers, making snow shoveling and other activities dangerous for some.

29 Feb 2012

Baxter commences CD34+ stem cell phase III trial in CMI

Baxter International Inc. announced today that it has initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (an individual's own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).

From Baxter International Inc. 28 Feb 2012

Stents not more beneficial than medications in stable coronary artery disease: Study

The placement of a stent to repair a narrowed artery in the heart has become routine worldwide. A new analysis of earlier clinical trials shows that inserting a stent has no benefit over standard medical care in treating stable coronary artery disease.

28 Feb 2012

Initial stent implantation does not appear to improve outcomes for patients with stable CAD

A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina, according to a study published in the Feb. 27 Archives of Internal Medicine, one of the JAMA/Archives journals.

28 Feb 2012

FDA approves Boston Scientific's ION and TAXUS Liberte paclitaxel-eluting stents

Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.

23 Feb 2012

Screening events to find out risk for heart attack or stroke

If you could find out if you had an increased risk of heart attack or stroke, wouldn't you want to know? Even if you are fit and healthy, coronary artery disease (CAD) or peripheral artery disease (PAD) are conditions with little to no symptoms and can put you at an increased risk of heart attack or stroke.

20 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Study finds poor QOL in South Asians with coronary artery disease

In a first-of-its-kind study in Canada, Kevin Bainey of the Faculty of Medicine & Dentistry has discovered that South Asians who live in Alberta with coronary disease experience a lower quality of life.

16 Feb 2012

St. Jude Medical to examine cost-effectiveness of FFR-guided therapy in Australia, Asia

St. Jude Medical, Inc., a global medical device company, announced today it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in Japan, China, India, Korea, and Australia.

15 Feb 2012

Second chance may be the last chance for heart attack patients

After he failed to heed the first big warning about his heart, John Magri was lucky to survive the second.

15 Feb 2012

Calcium scoring screening can effectively detect CAD

Heart disease tragically affects almost every family in the United States. It claimed more than 616,000 lives in 2008, the latest year for which statistics are available. Coronary artery disease is the most common type of heart disease and can lead to heart attacks, heart failure, strokes, arrhythmia and angina.

15 Feb 2012

Healthy, loving relationship is good for the heart

Being involved in a healthy, loving relationship is good for the heart, says Vanderbilt Heart and Vascular Institute cardiologist Julie Damp, M.D.

14 Feb 2012

Prevention and treatment options are improving long-term outcomes for heart failure

"Despite the increasing number of people affected, the prognosis for patients with heart failure has steadily improved," said Gregg C. Fonarow, M.D, chairman of American Heart Association Hospital Accreditation Science Committee and professor of cardiovascular medicine of the University of California, Los Angeles.

14 Feb 2012

Cardium to raise $5.0 million in registered direct offering

Cardium Therapeutics today announced that it has entered into definitive agreements with three institutional and accredited investors to sell an aggregate of 17,857,143 shares of its common stock in a registered direct offering for gross proceeds of approximately $5.0 million, before deducting placement agent's fees and estimated offering expenses.

13 Feb 2012

Y chromosome may be the link that passes heart disease risk from father to son

The study, published in The Lancet, focused on genetic markers on the Y chromosome — which is present only in male DNA (women have two X chromosomes) — and found that men with a certain genetic variant were 50% more likely to have coronary artery disease than those without it. The increased risk was independent of other contributors to heart disease such as age, weight, high cholesterol, high blood pressure and smoking.

12 Feb 2012

Link between coronary artery disease and prostate cancer

In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.

8 Feb 2012

First sign of coronary heart disease in men could be death

The healthy heart movement in recent years has focused largely on heart disease as the No. 1 killer of women. But the same statistic is true for men, and the reality is grim: The first sign that a man has coronary heart disease could be death, says one University of Alabama at Birmingham expert.

8 Feb 2012